By Raffaele Pace, Engineering Vice President of Operations, Stevanato Group
Personalized medicine and self-administration are two key trends gaining momentum and transforming the pharma landscape. And one crucial ingredient they both have in common is flexibility.
One size certainly doesn't fit all when it comes to injectable devices. Today's drug delivery devices need to be more mobile, less intrusive, simpler than ever before – and tailored to the needs of different patients. All while remaining cost-competitive.
The move towards at-home treatment accelerated during the COVID-19 pandemic as patients were encouraged to stay away from hospitals as much as possible. As a result, the need for user-friendly injectable devices – such as auto-injectors and pen injectors – is now greater than ever. They deliver drugs efficiently while mitigating many of the risks associated with self-injection – incorrect dosing and device misuse. User-friendly devices also help with patient adherence.